Indications for: TICOVAC
Active immunization to prevent tick-borne encephalitis (TBE).
Adults and Children:
<1yr: not established. Give by IM inj only. Primary vaccination (3-dose series): 1–15yrs: each dose is 0.25mL; give 1st dose at elected date, 2nd dose 1–3mos after the 1st dose, and 3rd dose 5–12mos after the 2nd dose. ≥16yrs: each dose is 0.5mL; give 1st dose at elected date, 2nd dose 14days–3mos after the 1st dose, and 3rd dose 5–12mos after the 2nd dose. Complete primary series at least 1 week prior to exposure to TBE virus. Booster vaccination (4th dose): may be given at least 3yrs after primary series if ongoing or re-exposure.
Immunocompromised. Have appropriate medical treatment and supervision readily available. Contains human albumin; potential risk for infection transmission (eg, viruses, Creutzfeldt-Jakob disease). Pregnancy. Nursing mothers.
Local tenderness/pain, headache, fever, restlessness, fatigue, muscle pain.
Generic Drug Availability:
Prefilled syringes (0.25mL, 0.5mL)—1, 10